Finance

Lists
BLTE:NASDAQ
Belite Bio Inc
$193.61
+13.16%
(+22.52) 1D
$193.61
0.00% (0.00)
After hours
Closed: Sep 4, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLTE...
Open
$172.77
High
$193.88
Low
$172.77
Mkt. cap
7.80B
Avg. vol.
170.30K
Volume
738.95K
52-wk high
$200.00
52-wk low
$65.00
EPS
-$2.85
Beta
-1.23
Shares outstanding
40.27M
No. of employees
41
Open
$172.77
High
$193.88
Low
$172.77
Mkt. cap
7.80B
Avg. vol.
170.30K
Volume
738.95K
52-wk high
$200.00
52-wk low
$65.00
EPS
-$2.85
Beta
-1.23
Shares outstanding
40.27M
No. of employees
41
News stories
From web sources and news partners
About Belite Bio Inc
CEO-
Employees41
Founded2016
Headquarters-
SectorPharmaceutical industry
Websitebelitebio.com
Analyst ratings
Based on 7 analysts giving stock ratings to BLTE in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BLTE in the last 3 months.
Highest
Current $193.61
$303.00 (+56.50%)
Average
$230.43 (+19.02%)
Lowest
$200.00 (+3.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
$220.00
+13.6%
09/04/2026
Whitney Ijem
Canaccord Genuity
Buy
Initiated
$303.00
+56.5%
09/04/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$214.00
+10.5%
09/03/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
$200.00
+3.3%
09/02/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
$206.00
+6.4%
08/17/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
$200.00
+3.3%
08/14/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$270.00
+39.5%
08/14/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
$217.00
+12.1%
03/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.31M
14.62M
15.66M
18.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.71M
13.45M
17.02M
16.69M
Operating expense
23.02M
28.08M
32.68M
34.91M
Total operating expenses
23.02M
28.08M
32.68M
34.91M
Operating income
-23.02M
-28.08M
-32.68M
-34.91M
Other non operating income
-2.14M
-417.00K
5.75M
6.55M
EBT including unusual items
-21.69M
-25.32M
-26.94M
-28.36M
EBT excluding unusual items
-21.69M
-25.32M
-26.94M
-28.36M
Income tax expense
-
-
-
55.00K
Effective tax rate
-
-
-
-0.19%
Other operating expenses
-
-
-
-
Net income
-21.69M
-25.32M
-26.94M
-28.41M
Net profit margin
-
-
-
-
Earnings per share
-0.65
-0.70
-0.68
-0.70
Interest and investment income
3.47M
3.17M
-
-
Interest expense
-
-2.00K
-
-
Net interest expenses
3.47M
3.17M
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.97M
-28.03M
-32.64M
-34.86M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps